Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 11:12:96.
doi: 10.1186/1741-7015-12-96.

Outpatient antibiotic prescribing in the United States: 2000 to 2010

Affiliations

Outpatient antibiotic prescribing in the United States: 2000 to 2010

Grace C Lee et al. BMC Med. .

Abstract

Background: The use of antibiotics is the single most important driver in antibiotic resistance. Nevertheless, antibiotic overuse remains common. Decline in antibiotic prescribing in the United States coincided with the launch of national educational campaigns in the 1990s and other interventions, including the introduction of routine infant immunizations with the pneumococcal conjugate vaccine (PCV-7); however, it is unknown if these trends have been sustained through recent measurements.

Methods: We performed an analysis of nationally representative data from the Medical Expenditure Panel Surveys from 2000 to 2010. Trends in population-based prescribing were examined for overall antibiotics, broad-spectrum antibiotics, antibiotics for acute respiratory tract infections (ARTIs) and antibiotics prescribed during ARTI visits. Rates were reported for three age groups: children and adolescents (<18 years), adults (18 to 64 years), and older adults (≥65 years).

Results: An estimated 1.4 billion antibiotics were dispensed over the study period. Overall antibiotic prescribing decreased 18% (risk ratio (RR) 0.82, 95% confidence interval (95% CI) 0.72 to 0.94) among children and adolescents, remained unchanged for adults, and increased 30% (1.30, 1.14 to 1.49) among older adults. Rates of broad-spectrum antibiotic prescriptions doubled from 2000 to 2010 (2.11, 1.81 to 2.47). Proportions of broad-spectrum antibiotic prescribing increased across all age groups: 79% (1.79, 1.52 to 2.11) for children and adolescents, 143% (2.43, 2.07 to 2.86) for adults and 68% (1.68, 1.45 to 1.94) for older adults. ARTI antibiotic prescribing decreased 57% (0.43, 0.35 to 0.52) among children and adolescents and 38% (0.62, 0.48 to 0.80) among adults; however, it remained unchanged among older adults. While the number of ARTI visits declined by 19%, patients with ARTI visits were more likely to receive an antibiotic (73% versus 64%; P <0.001) in 2010 than in 2000.

Conclusions: Antibiotic use has decreased among children and adolescents, but has increased for older adults. Broad-spectrum antibiotic prescribing continues to be on the rise. Public policy initiatives to promote the judicious use of antibiotics should continue and programs targeting older adults should be developed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Antibiotic prescribing in the United States, 2000 to 2010. Data are from the Medical Expenditure Panel Surveys. Error bars indicate 95% confidence intervals. Rates are per 1,000 population.
Figure 2
Figure 2
Age-based antibiotic prescribing in the United States, 2000 to 2010. Data are from the Medical Expenditure Panel Surveys. Error bars indicate 95% confidence intervals. Rates are per 1,000 population.
Figure 3
Figure 3
Broad-spectrum antibiotic prescribing during acute respiratory tract infection visits in the United States, 2000 to 2010. *P <0.0001. Acute respiratory tract infection includes acute nasopharyngitis, upper respiratory tract infection, bronchitis, influenza, pharyngitis and sinusitis. Data are from the Medical Expenditure Panel Surveys. Error bars represent 95% confidence intervals. Rates are per 1,000 population.

References

    1. Acar JF, Kaplan EL, O’Brien TF. Monitoring and management of bacterial resistance to antimicrobial agents: A World Health Organization symposium. Clin Infect Dis. 1997;24:S1–S176. doi: 10.1093/clinids/24.Supplement_1.S1. - DOI - PubMed
    1. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: A population perspective. Emerg Infect Dis. 2002;8:347–354. doi: 10.3201/eid0804.010312. - DOI - PMC - PubMed
    1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: No ESKAPE! an update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12. doi: 10.1086/595011. - DOI - PubMed
    1. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J Jr. Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:155–164. doi: 10.1086/524891. - DOI - PubMed
    1. Network for Excellence in Health Innovation. How many more studies will it take? A collection of evidence that our health care system can do better. http://www.nehi.net/writable/publication_files/file/how_many_more_studie.... Accessed 10 March 2013.

MeSH terms